Inflows into U.S. spot bitcoin ETFs have stagnated this year compared with 2024.
FedEx shares slide as annual forecast cuts stoke worries on economy
(Reuters) -FedEx's shares fell 11% on Friday after the parcel delivery firm cut its annual forecasts, fanning worries about the health of U.S. manufacturing amid uncertainty from the Trump administration's sweeping tariffs on trading partners. CEO Raj Subramaniam warned a day earlier that the company was navigating a very "challenging operating environment" and "weakness in the industrial economy" was weighing on its higher-margin business-to-business volumes. The company's shares hit their lowest in nearly two years on Friday.
Do This One Thing, and You'll Make Vastly Better Cryptocurrency Investments Today
Everyone wants an edge when it comes to investing in highly volatile assets like XRP (CRYPTO: XRP), Solana (CRYPTO: SOL), Ethereum (CRYPTO: ETH) and other cryptocurrencies. If you're like most people who hold cryptocurrencies, you probably broadly understand that such assets live on blockchains, which in theory can give them certain properties that dollars in your bank account can't have, like being linked to something such as ownership of a non-fungible token (NFT). Thus, the one thing that can dramatically improve your investment research process in crypto (and therefore your returns) is to get your hands dirty by working with the actual technology underpinning your coins rather than simply pressing "buy" or "sell" and then letting them sit quietly in your portfolio.
3 Reasons to Avoid DOV and 1 Stock to Buy Instead
Dover currently trades at $181.55 per share and has shown little upside over the past six months, posting a small loss of 5%.
3 Reasons to Avoid JELD and 1 Stock to Buy Instead
What a brutal six months it’s been for JELD-WEN. The stock has dropped 61.7% and now trades at $6.11, rattling many shareholders. This might have investors contemplating their next move.
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Royalty Pharma (NASDAQ:RPRX) and the rest of the branded pharmaceuticals stocks fared in Q4.
A Look Back at Beverages, Alcohol, and Tobacco Stocks’ Q4 Earnings: Celsius (NASDAQ:CELH) Vs The Rest Of The Pack
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Celsius (NASDAQ:CELH) and its peers.
Q4 Rundown: Deere (NYSE:DE) Vs Other Agricultural Machinery Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the agricultural machinery industry, including Deere (NYSE:DE) and its peers.
Reflecting On Gas and Liquid Handling Stocks’ Q4 Earnings: Chart (NYSE:GTLS)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Chart (NYSE:GTLS) and its peers.
Winners And Losers Of Q4: Wendy's (NASDAQ:WEN) Vs The Rest Of The Traditional Fast Food Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at traditional fast food stocks, starting with Wendy's (NASDAQ:WEN).